Abstract
Beginning with studies at the turn of the century using crude anti-kidney antisera, anti-glomerular basement membrane (GBM) antibody disease has become the clearest example of antibody-induced glomerular injury (1). In animal studies, it can be clearly shown that glomerular injury produced by anti-GBM antibodies is dose dependent and that temporal features of glomerular binding affect the extent of the inflammatory response and, in turn, the degree of injury induced. The experimental anti-GBM antibody model has been used widely to demonstrate the roles of inflammatory mediators. These mediators include humoral factors such as the complement proteins (both early- and late-acting components) and cellular elements including polymorphonuclear (PMN) leukocytes, monocytes/macrophages, and the enzymatic, oxidative, and other iflammatory elements contained therein (1–3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilson CB, Dixon FJ: The renal response to immunological injury. In: BM Brenner, FC Rector Jr, eds, The Kidney, 3rd ed. WB Saunders, Philadelphia, pp 800–889, 1986.
Cybulsky AV, Quigg RJ, Salant DJ: Role of the complement membrane attack complex in glomerular injury. In: BM Brenner, JH Stein, eds, CB Wilson, guest ed, Contemporary Issues in Nephrology. Churchill-Livingstone, New York, 1988, pp 57–86.
Johnson RJ, Klebanoff SJ, Couser WG: Oxidants in glomerular injury. In: BM Brenner, JH Stein, eds, CB Wilson, guest ed, Contemporary Issues in Nephrology. Churchill-Livingstone, New York, 1988, pp 87–110.
Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989–1004, 1967.
Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3:74–89, 1973.
Wilson CB, Dixon FJ: Diagnosis of immunopathologic renal disease, (editorial) Kidney Int 5:389–401, 1974.
Leatherman JW, Sibley RK, Davies SF: Diffuse intrapulmon-ary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody. Am I Med 72:401–410, 1982.
Boyce NW, Holdsworth SR: Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis 8:31–36, 1986.
Wilson CB: Immunologic diseases of the lung and kidney (Goodpasture’s syndrome). In: AP Fishman, ed, Pulmonary Diseases and Disorders, 2nd ed. McGraw-Hill New York, 1988.
van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1:425–429, 1985.
Lockwood CM, Bakes D, Jones S, Whitaker KB, Moss DW, Savage CO: Association of alkaline phosphatase with an autoantigen recognized by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet 1:716–720, 1987.
Falk RJ, Terrell R, Jennette JC: Anti-granulocyte cytoplasmic autoantibody (AGCA) specific for myeloperoxidase (MPO) in vasculitis related and idiopathic necrotizing and crescentic glomerulonephritis (abstract) Kidney Int 33:313, 1988.
Lockwood CM, Jayne DR, Marshall P, Jones S, Savage COS: A prospective study of the incidence of anti-GBM and anti-neutrophil cytoplasm antibodies in patients with rapidly progressive nephritis (abstract). Kidney Int 33:329, 1988.
McCoy RC, Johnson HK, Stone WJ, Wilson CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21:642–652, 1982.
Savage COS, Pusey CD, Bowman C, Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody mediated disease in the British Isles 1980–4. Br Med J 292:301–304, 1986.
Rees AJ, Peters K, Amos N, Welsh KI, Batchelor JR: The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int 26:444–450, 1984.
Andres G, Brentjens J, Kohli R, Anthone R, Anthone S, Baliah T, Montes M, Mookerjee BK, Prezyna A, Sepulveda M, Venuto R, Elwood C: Histology of human tubulo-interstitial nephritis associated with antibodies to renal basement membranes. Kidney Int 13:480–491, 1978.
Beechler CR, Enquist RW, Hunt KK, Ward GW, Knieser MR: Immunofluorescence of transbronchial biopsies in Goodpasture’s syndrome. Am Rev Respir Dis 121:869–872, 1980.
Johnson JP, Moore J, Jr, Austin HA, III, Balow JE, Antonovych TT, Wilson CB: Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64:219–277.21, 1985.
Jennings L, Roholt OA, Pressman D, Blau M, Andres GA, Brentjens JR: Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. J Immunol 127:129–134, 1981.
Downie GH, Roholt, OA, Jennings L, Blau M, Brentjens JR, Andres GA: Experimental anti-alveolar membrane antibody-mediated pneumonitis. II. Role of endothelial damage and repair, induction of autologous phase, and kinetics of antibody deposition in Lewis rats. J Immunol 129:2647–2652, 1982.
Yamamoto T, Wilson CB: Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. Am J Pathol 126:497–505, 1987.
Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM: Idiopathic crescentic glomerulonephritis. Medicine 56:349–381, 1977.
Rees AJ, Lockwood CM, Peters DK: Enhanced allergic tissue injury in Goodpasture’s syndrome by intercurrent bacterial infection. Br Med J 2:723–726, 1977.
Donaghy M, Rees AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 2:1390–1393, 1983.
Leaker B, Walker RG, Becker GJ, Kincaid-Smith P: Cigarette smoking and lung hemorrhage in anti-glomerular-basement-membrane neprhritis. Lancet 2:1039, 1984.
Wilson CB: Drug- and toxin-induced nephritides: Anti-kidney antibody and immune complex mediation. In: G Porter, ed, Nephrotoxic Mechanisms of Drugs and Environmental Toxins. Plenum, New York, pp 383–392, 1982.
Wilson CB, Marquardt H, Dixon FJ: Radioimmunoassay (RIA) for circulating antiglomerular basement membrane (GBM) antibodies.Kidney Int 6:114a, 1974.
Wilson CB: Radioimmunoassay for anti-glomerular basement membrane antibodies. In: NR Rose, H Friedman, eds, Manual of Clinical Immunology, 2nd ed. American Society for Microbiology, Washington DC, pp 886–894, 1980.
Fish AJ, Kleppel M, Jeraj K, Michael AF: Enzyme immunoassay of anti-glomerular basement membrane antibodies. J Lab Clin Med 105:700–705, 1985.
Bowman C, Lockwood CM: Clinical application of a radioimmunoassay for auto-antibodies to glomerular basement membrane. J Clin Lab Immunol 17:197–202, 1985.
Wilson CB, Holdsworth SR: Anti-glomerular basement membrane (GBM) antibody-induced disease. In: W Zurukzoglu, M Papadimitriou, M Pyrpasopoulos, M Sion, C Zam-boulis, eds, Proceedings of the 8th International Congress of Nephrology. S Karger, Basel, pp 910–916, 1981.
Wieslander J, Barr JF, Butkowski RJ, Edwards SJ, Bygren P, Heinegard D, Hudson BG: Goodpasture antigen of the glomerular basement membrane: Localization of noncoloagenous regions of type IV collagen. Proc Natl Acad Sci USA 81:3838–3842, 1984.
Kefalides NA, Ohno N, Wilson CB: Antigenic components of bovine lens capsule that cross-react serum from Goodpasture’s syndrome. Fed Proc 43:779, 1984.
Wieslander J, Heinegard D: The involvement of Type IV collagen in Goodpasture’s syndrome. Ann NY Acad Sci 460:363–374, 1985.
Butkowski RJ, Wieslander J, Wisdom BJ, Barr JR, Noelken ME, Hudson BG: Properties of the globular domain of Type IV collagen and its relationship to the Goodpastures antigen. J Biol Chem 260:3739–3747, 1985.
Timpl R: Recent advances in the biochemistry of glomerular basement membrane. Kidney Int 30:293–298, 1986.
Butkowski RJ, Langeveld JPM, Wieslander J, Hamilton J, Hudson BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen (abstract). Proceedings of the Xth International Congress of Nephrology, London, 1987.
Kefalides NA, Abrams WR, Ohno N, Wilson CB, Rosenbloom J: Indentification of antigenic determinants in the NC-1 domain of Type IV collagen reactive with Goodpasture sera (abstract) FASEB J 2:A629, 1988.
Yaar M, Foidart JM, Brown KS, Rennard SI, Martin GR, Liotta L: The Goodpasture-like syndrome in mice induced by intravenous injections of an-Type IV collagen and anti-laminin antibody. Am J Pathol 107:79–91, 1982.
Makino H, Gibbons JT, Reddy MK, Kanwar YS: Nephri-togenicity of antibodies to proteoglycans of the glomerular basement membrane-I. J Clin Invest 77:142–156, 1986.
Miettinen A, Stow JL, Mentone S, Farquhar MG: Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 163:1064–1084, 1986.
Feintzeig ID, Abrahamson DR, Cybulsky AV, Dittmer JE, Salant DJ: Nephritogenic potential of sheep antibodies against glomerular basement membrane laminin in the rat. Lab Invest 54:531–541, 1986.
Szarfman A, Terranova VP, Rennard SI, Foidart JM, De Fatima M, Scheinman JI, Martin GR: Antibodies to laminin in Chagas’ disease. J Exp Med 155:1161–1171, 1982.
Fillit H, Damle SP, Gregory JD, Volin C, Poon-King T, Zabriskie J: Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med 161:277–289, 1985.
Kefalides NA, Pegg MT, Ohno N, Poon-King T, Zabriskie J, Fillit H: Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis. J Exp Med 163:588–602, 1986.
Cederholm B, Wieslander J, Bygren P, Heinegard D: Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc Natl Acad Sci USA 83:6151–6155, 1986.
Steblay RW: Glomerulonephritis induced in sheep by injection of heterologous glomerular basement membrane in Freund’s complete adjuvant. J Exp Med 116:253–271, 1962.
Bygren P, Wieslander J, Heinegard D: Glomerulonephritis induced in sheep by immunization with human glomerular basement membrane. Kidney Int 31:25–31, 1987.
Wick G, Von der Mark J, Doetrocj H, Timpl R: Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease. Lab Invest 55:308–317, 1986.
Yoshioka K, Kleppel M, Fish AJ: Analysis of nephritogenic antigens in human glomerular basement membrane by two-dimensional gel electrophoresis. J Immunol 134:3831–3837, 1985.
Zanetti M, Wilson CB: Characterization of anti-tubular basement membrane antibodies in rats. J Immunol 130:2173–2179, 1983.
Jeraj K, Kim Y, Vernier RL, Fish AJ, Michael AF: Absence of Goodpasture’s antigen in male patients with familial nephritis. Am J Kidney Dis 6:626–629, 1983.
Savage COS, Pusey CD, Kershaw MJ, Cashman SJ, Harrison P, Hartley B, Turner DR, Cameron JS, Evans DJ, Lockwood CM: The Goodpasture antigen in Alport’s syndrome: Studies with a monoclonal antibody. Kidney Int 30:107–112, 1986.
Savage COS, Reed A, Kershaw M, Pincott J, Pusey CD, Dillon MJ, Barratt TM, Lockwood CM: Use of a monoclonal antibody in differential diagnosis of children with haematuria and hereditary nephritis. Lancet 1:1459–1461, 1986.
Jeraj K, Fish AJ, Yoshioka K, Michael AF: Development and heterogeneity of antigens in the immature nephron: Reactivity with human anti-glomerular basement membrane autoantibodies. Am J Pathol 117:180–183, 1984.
Yoshioka K, Michael AF, Velosa J, Fish AJ: Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am J Pathol 121:156–165, 1985.
Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78:1035–1044, 1986.
Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK, Wilson CB: Recovery from Goodpasture’s syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 2:252–254, 1975.
Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P: Clinical and morphologic aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture’s syndrome. Q J Med 54:75–89, 1985.
Almkuist RD, Buckalew VM, Hirszel P, Mäher JF, James PM, Wilson CB: Recurrence of anti-glomerular basement membrane antibody mediated glomerulonephritis in an isog-raft. Clin Immunol Immunopathol 18:54–60, 1981.
Cove-Smith JR, McLeod AA, Blarney RW, Knapp MS, Reeves WG, Wilson CB: Transplantation, immunosuppression and plasmapheresis in Goodpasture’s syndrome. Clin Nephrol 9:126–128, 1978.
Jansen B, Thorner PS, Singh A, Patterson JM, Lumsden JH, Valli VE, Baumal R, Basrur PK: Hereditary nephritis in Samoyed dogs. Am J Pathol 116:175–178, 1984.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Wilson, C.B. (1991). Goodpasture’s Syndrome. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive